Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.

Baek HJ, Kim JS, Yoon M, Lee JJ, Shin MG, Ryang DW, Kook H, Kim SK, Cho D.

Anticancer Res. 2013 May;33(5):2011-9.

PMID:
23645750
2.

Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.

Lim SA, Kim TJ, Lee JE, Sonn CH, Kim K, Kim J, Choi JG, Choi IK, Yun CO, Kim JH, Yee C, Kumar V, Lee KM.

Cancer Res. 2013 Apr 15;73(8):2598-607. doi: 10.1158/0008-5472.CAN-12-2893. Epub 2013 Apr 11.

3.

Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.

Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H.

Biol Blood Marrow Transplant. 2008 Sep;14(9):1031-8. doi: 10.1016/j.bbmt.2008.06.016.

4.

A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.

Vasu S, Berg M, Davidson-Moncada J, Tian X, Cullis H, Childs RW.

Cytotherapy. 2015 Nov;17(11):1582-93. doi: 10.1016/j.jcyt.2015.07.020.

PMID:
26432560
5.

Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.

Kim EK, Ahn YO, Kim S, Kim TM, Keam B, Heo DS.

Cytotherapy. 2013 Feb;15(2):231-241.e1. doi: 10.1016/j.jcyt.2012.10.019.

PMID:
23321334
6.

[Enhanced cytotoxicity against leukemia cells of natural Killer cells from cord blood after expansion in vitro].

Zhou F, Han WM, Jia ZX, Yang JH, Xiao R, Ma LD, Lu XZ.

Zhonghua Xue Ye Xue Za Zhi. 2013 Nov;34(11):952-6. doi: 10.3760/cma.j.issn.0253-2727.2013.11.009. Chinese. Retraction in: Zhonghua Xue Ye Xue Za Zhi. 2014 Jan;35(1):76.

PMID:
24294851
7.

[Expansion of human natural killer cells ex vivo].

Huang QS, Li Q, Huang Y, Shang P, Zhang MJ.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Dec;24(12):1167-9. Chinese.

PMID:
19068202
8.

Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.

Condiotti R, Zakai YB, Barak V, Nagler A.

Exp Hematol. 2001 Jan;29(1):104-13.

PMID:
11164111
9.

Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.

Phan MT, Lee SH, Kim SK, Cho D.

Methods Mol Biol. 2016;1441:167-74. doi: 10.1007/978-1-4939-3684-7_14.

PMID:
27177665
10.
11.

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.

Spanholtz J, Tordoir M, Eissens D, Preijers F, van der Meer A, Joosten I, Schaap N, de Witte TM, Dolstra H.

PLoS One. 2010 Feb 15;5(2):e9221. doi: 10.1371/journal.pone.0009221.

12.

Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells.

Park YK, Shin DJ, Cho D, Kim SK, Lee JJ, Shin MG, Ryang DW, Lee JS, Park MH, Yoon JH, Jegal YJ.

Anticancer Res. 2012 Mar;32(3):839-46.

PMID:
22399602
13.

Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.

Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.

Exp Hematol. 2009 Oct;37(10):1216-29. doi: 10.1016/j.exphem.2009.07.009. Epub 2009 Jul 26.

PMID:
19638292
14.
15.

Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.

Klöß S, Oberschmidt O, Morgan M, Dahlke J, Arseniev L, Huppert V, Granzin M, Gardlowski T, Matthies N, Soltenborn S, Schambach A, Koehl U.

Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15.

PMID:
28810809
16.

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.

Lapteva N, Durett AG, Sun J, Rollins LA, Huye LL, Fang J, Dandekar V, Mei Z, Jackson K, Vera J, Ando J, Ngo MC, Coustan-Smith E, Campana D, Szmania S, Garg T, Moreno-Bost A, Vanrhee F, Gee AP, Rooney CM.

Cytotherapy. 2012 Oct;14(9):1131-43. doi: 10.3109/14653249.2012.700767. Epub 2012 Aug 17.

17.

Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.

Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G.

Cell Stress Chaperones. 2008 Summer;13(2):221-30. doi: 10.1007/s12192-007-0008-y. Epub 2008 Feb 26.

18.

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells.

Zhang M, Daniel S, Huang Y, Chancey C, Huang Q, Lei YF, Grinev A, Mostowski H, Rios M, Dayton A.

BMC Immunol. 2010 Jan 20;11:3. doi: 10.1186/1471-2172-11-3.

19.

Expansion, purification, and functional assessment of human peripheral blood NK cells.

Somanchi SS, Senyukov VV, Denman CJ, Lee DA.

J Vis Exp. 2011 Feb 2;(48). pii: 2540. doi: 10.3791/2540.

20.

Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells.

Deng X, Terunuma H, Terunuma A, Takane T, Nieda M.

Int Immunopharmacol. 2014 Oct;22(2):486-91. doi: 10.1016/j.intimp.2014.07.036. Epub 2014 Aug 11.

PMID:
25131561

Supplemental Content

Support Center